Skip to main content
Springer logoLink to Springer
. 2017 Nov 10;22(3):1053–1061. doi: 10.1007/s10461-017-1973-5

‘Test and Treat’ Among Women at High Risk for HIV-infection in Kampala, Uganda: Antiretroviral Therapy Initiation and Associated Factors

Yunia Mayanja 1,, Onesmus Kamacooko 1, Daniel Bagiire 1, Gertrude Namale 1, Pontiano Kaleebu 1, Janet Seeley 1,2
PMCID: PMC5847220  PMID: 29127534

Abstract

Data on implementation of ‘Test and Treat’ among key populations in sub-Saharan Africa are still limited. We examined factors associated with prompt antiretroviral therapy/ART (within 1 month of HIV-positive diagnosis or 1 week if pregnant) among 343 women at high risk for HIV infection in Kampala-Uganda, of whom 28% initiated prompt ART. Most (95%) reported paid sex within 3 months prior to enrolment. Multivariable logistic regression was used to determine baseline characteristics associated with prompt ART. Sex work as main job, younger age and being widowed/separated were associated with lower odds of prompt ART; being enrolled after 12 months of implementing the intervention was associated with higher odds of prompt ART. Younger women, widowed/separated and those reporting sex work as their main job need targeted interventions to start ART promptly after testing. Staff supervision and mentoring may need strengthening during the first year of implementing ‘test and treat’ interventions.

Keywords: HIV, High risk women, Test and treat, Anti-retroviral therapy, Uganda (sub Saharan Africa)

Introduction

Throughout the world, key populations who include: sex workers, injecting drug users (IDU), men who have sex with men (MSM), transgender people and fisher-folk are disproportionately burdened by the HIV epidemic [15]. These key populations and their sexual partners account for 10–51% of new infections in sub-Saharan Africa (SSA) [68]. Systematic reviews show that in low and middle income countries (LMICs), female sex workers (FSWs) are 13.5 times more likely to have HIV compared to women in the general population [1]. In Uganda, while the National HIV prevalence has stabilized at 7.3% [9], the prevalence is over 30% among FSWs [10].

The HPTN052 trial showed that immediate ART given to HIV-positive people dramatically reduced HIV-transmission to their HIV-negative partners [11]. These results were received with considerable enthusiasm and the ‘end of AIDS’ heralded [12, 13]. In December 2013, the Ministry of Health (MoH), Government of the Republic of Uganda, issued an ‘Addendum to the National Antiretroviral Treatment Guidelines’ which allowed provision of ART irrespective of CD4 T cell counts to the following HIV-positive groups: pregnant women and breast-feeding mothers, partners in sero-discordant couples, and people with active TB disease or Hepatitis B co-infection with severe chronic liver disease. In addition, it included the recommendation that key populations should initiate prompt ART [14] with the rationale that these groups were making a substantial contribution to new HIV infections. Following the START trial results [15], and the release of the WHO ‘Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV’ [16], the global HIV response is now aimed at reducing HIV transmission by giving prompt ART to all HIV-positive people, a challenging and ambitious goal [17]. This approach is called `Test and Treat’ or `Test and Start’ [18].

The studies that have assessed ‘test and treat’ in sub-Saharan Africa (SSA) have shown that at least half of participants initiate prompt ART [19, 20]. In the PopART trial, the largest so far to deliver ‘test and treat’ at population level, Hayes et al. report less than 45% ART uptake within 6 months with uptake being lower among the younger population [21]. Among MSM in Nigeria prompt ART was associated with disclosure of MSM status [20] while in a cluster randomised trial among the general population in South Africa, participants in the ‘test and treat’ arm were less likely to initiate ART if they had high CD4 T-cell counts, most likely because they were not sick [19]. Studies done among the general population elsewhere, and key populations such as MSM and FSWs also show that being in a healthy state [2225] is associated with lower ART uptake. Fear of side effects [25, 26] has been reported as another barrier to prompt ART.

The enthusiasm for `Test and Treat’ has been tempered by a growing recognition of the challenges that impede progress in providing treatment to everyone living with HIV [21, 2731] and achieving the second ‘90’ of the UNAIDS 90–90–90 targets. Despite these challenges, concerns over the spread of HIV [32] and the prospect of increased ART drug resistance in Africa [33] have increased efforts to facilitate the roll-out of treatment and identify barriers to initiating prompt ART. We build on work done in the general population [19, 21] and MSM [20] to determine factors associated with prompt ART initiation among FSWs, who are criminalized in many parts of SSA and in whom the dynamics of treatment uptake may differ from the general population and settings that have decriminalized sex work. We hypothesize that treatment uptake will be different from that seen in the general population. We use data collected over 2 years and 8 months in a ‘Test and Treat’ intervention in Kampala, Uganda.

Methods

Study Design and Setting

We performed a retrospective cohort analysis of participant records within a research clinic implementing ‘Test and Treat’ among women at high risk for HIV infection, who attended the clinic between August 2014 and April 2017. The clinic (Good Health for Women Project Clinic-GHWP) was established in a peri-urban community in southern Kampala in 2008. Women attending the clinic engage in sex with men for money, goods or favors; the recruitment of women from commercial hotspots has been described elsewhere [10].

Women are enrolled into the GHWP clinic irrespective of HIV status, and invited for quarterly visits for HIV prevention and care services. At enrolment, women are offered HIV counselling and testing (HCT) and receive same day results. HIV-positive participants received free HIV care including Tuberculosis screening and treatment, prophylaxis for opportunistic infections (OIs) and ART. ART was initiated using CD4 + T-cell counts (< 350 cells/µl) and WHO clinical stage criteria until August 2014 when the clinic implemented ‘Test and Treat’ in line with the new MoH guidelines.

Repeat HCT was done at quarterly follow up visits only for women who previously tested HIV-negative. The women received free services including treatment for common illnesses, contraception, syndromic management of sexually transmitted infections (STIs), counselling for alcohol use disorders, male and female condoms and treatment for their children below 5 years. They were encouraged to refer their male regular partners to the clinic for HIV prevention, care and treatment interventions. Enrolment of women continued throughout the study period and field workers maintained contact details of enrolled participants.

Study Participants, Eligibility Criteria

We selected participants from all HIV-positive ART-naïve women who were newly enrolled in the clinic from August 2014 to April 2017 and who were ≥ 18 years. In addition, all HIV-negative women who changed to HIV positive status (HIV seroconversion) during the study period became eligible.

ART Preparation, Initiation and Follow up Process

Study counsellors gave group information sessions about the ‘Test and Treat’ guidelines to participants and the benefits to their health and the wider community. Women were also counselled on disclosure, drug reactions and adherence, and then individually assessed for readiness to start ART using the ART readiness checklist. Women who were ready, initiated ART on the same day. Those who opted out of same-day initiation continued to be counselled, and a plan made with the aim of initiating ART within 7 days for pregnant women, and within 1 month for the others. Women were considered to have initiated prompt ART if they started treatment within 1 month or 1 week (if pregnant) of an HIV-positive diagnosis as per the “Consolidated guidelines for prevention and treatment of HIV in Uganda” [34]. Counselling sessions during clinic visits continued for those who did not initiate prompt ART. They continued to be followed up at the clinic to receive free services and treatment of other illnesses, and could initiate ART when they were ready. The women initiated first line treatment composed of two nucleoside reverse transcriptase inhibitors (NRTIs) and one non-nucleoside reverse transcriptase inhibitor (NNRTI); they were initially given 2 week’s treatment and scheduled for follow up 2 weeks later but were free to return earlier if they experienced side effects or other challenges. Women were then given treatment for 1 month, and the interval increased to 2 months’ treatment if they had no clinical events or adherence problems. Those who adhered and tolerated the drugs well were then given 3 months of treatment and scheduled for quarterly visits onwards. ART was provided free of charge throughout the study period. The women gave blood samples for laboratory monitoring according to the MoH guidelines. CD4 + T-cell counts were tested at baseline and every 6 months, and viral load monitoring after at least 6 months on ART.

Study Outcomes

Prompt ART initiation was defined as dispensing initial ART to an eligible participant within 1 month of an HIV-positive diagnosis or within 1 week if pregnant.

Independent variables were collected at the time of HIV diagnosis and included: socio-demographic variables (age, marital status, education level, religion, main job); behavioral variables included: paid sex, substance use, contraceptive use and sexual partner violence in the 1 months prior to enrolment; condom use 1 month prior to enrolment and history of ever testing for HIV); one biological variable (CD4 T-cell count). We also included a time variable that measured the duration between ‘test and treat implementation and becoming eligible.

Data Collection

Data on socio-demographics, sexual behavior, prior HIV testing, substance use, contraception and sexual partner violence were collected using electronic (MS Access) interviewer administered questionnaires during one on one private sessions held in clinic rooms with trained study counsellors. Alcohol use was assessed by using the Alcohol Use Disorders Identification Test (AUDIT) questionnaire which consists of 10 questions to assess alcohol use disorders. Alcohol use was classified into two categories which included: low risk drinkers: score 0–7 and high risk drinkers: score 8 + . Data on ART start dates, duration on ART and prescriptions were recorded by clinicians. HIV results were recorded on laboratory source documents by laboratory staff while CD4 results were generated as print outs. Data on HIV results and ART were entered into OpenMRS by data management assistants.

Laboratory Methods

HIV testing was performed on serum using two or more rapid diagnostic tests for antibodies to HIV. Screening was performed using Determine. A non-reactive test result was given to the participant as HIV-negative while a reactive test was confirmed using Statpak. A reactive Statpak result was given to the participant as HIV-positive. Discordant determine and Statpak results, were subjected to a tie breaker test using Unigold. The result given by Unigold was taken as final for presence or absence of antibodies to HIV and results given to the participant.

CD4 testing was performed on plasma using Multi-test Trucount tube CD4/CD8/CD3-Lyse no wash (BD. USA).

Statistical Analysis

The MS Access and OpenMRS databases were merged into one database, cleaned, and exported to STATA 12.1 (StataCorp, College Station, TX, USA) for analysis. Prompt ART initiation was a binary outcome (Yes initiated prompt ART; No did not initiate prompt ART). Participants’ categorical demographic and behavioral characteristics were summarized by counts and percentages. Continuous characteristics were summarized by means and standard deviations (SD) or medians and inter quartile ranges. We determined the proportion who initiated prompt ART as the number that started ART within 1 month of eligibility (non-pregnant) or within 1 week (pregnant) divided by the total number eligible, and expressed as a percentage. The proportion who initiated prompt ART was further analyzed by the different demographic and behavioral characteristics using Chi square tests. Logistic regression models were fitted to find factors associated with prompt ART initiation at unadjusted analysis; those for which the association attained statistical significance on log likelihood ratio test (LRT), p < 0.20 were selected for the multivariable logistic regression model. We used complete case analysis to run our final model. Age was considered as a priori confounder. Factors were retained in the final multivariable logistic regression model if their inclusion did not make the model significantly worse at p < 0.05. Results are presented as adjusted odds ratios (AOR) with p values and 95% confidence intervals (CI).

Results

Recruitment Profile

The recruitment profile for participants is summarized in Fig. 1. From August 2014 to April 2017, we enrolled 2385 women at high risk of HIV-infection at the GHWP clinic. Of these 847 were HIV-positive of whom 354 were not yet on ART and were therefore eligible for ‘test and treat’. In addition, women joined the `test and treat cohort’ during the study period, because 44 participants who were HIV-negative became HIV-positive during the study period. Therefore, a total of 398 (354 + 44) participants were eligible, of whom 343 had complete data for all variables and were included in our final analysis.

Fig. 1.

Fig. 1

Screening profile of study participants

Characteristics of Study Participants

The mean (± SD) age of study participants was 28.9 ± 6.1 years. The majority (73.5%) were widowed or separated, 60.4% had primary level education and 65.6% were Christian. The median (IQR) CD4 + T-cell count at enrolment was 544 (327–775) cells/µl. Ninety-five percent of participants reported engaging in paid sex in the 3 months prior to enrollment. Overall, 65.3% of participants reported sex work as their main job, 20.1% mainly worked in entertainment facilities (bars, night clubs and karaoke) and the rest reported having other main job(s) such as the hospitality industry (restaurants, beauty and massage parlors, guest houses) or no job. High risk alcohol consumption was reported by 61.5% of all participants. Thirty-five percent consumed drugs, the most common being kuber/smokeless chewing tobacco and khat. Sexual partner violence was reported by 48.7% and was perpetrated by both casual partners and marital partners. Details are shown in Table 1.

Table 1.

Sociodemographic and behavioural characteristics of study participants

Characteristic Categories Frequency (n = 343) Percentage (%)
Age < 25 90 26.2
25–29 111 32.4
30–34 71 20.7
≥ 35 71 20.7
Education level No education 31 9.0
Attended primary 207 60.4
Attended Secondary or higher 105 30.6
Current marital status Never married 67 19.5
Married 24 7.0
Widowed/Separated 252 73.5
Religion Christian 225 65.6
Muslim and other 118 34.4
Main job Sex work 224 65.3
Entertainment 69 20.1
No job/other job 50 14.6
Paid sex in past 3 months Yes 324 94.5
No 19 5.5
Drinking pattern (AUDIT score) Low risk drinkers 132 38.5
High risk drinkers 211 61.5
Sexual partner violence in past 3 months Yes 167 48.7
No 176 51.3
HIV sero-conversion Yes 31 9.0
No 312 91.0
Ever tested for HIV  Yes 298 86.9
No 45 13.1
Drug use in past 3 months Yes 120 35.0
No 223 65.0
Time since T&T implementation 12 months 112 32.7
> 12 months 231 67.3

Factors Associated with Prompt ART Initiation

A total of 96 (28%) participants initiated prompt ART during the study period, the median time to ART initiation being 6 days (IQR 0–14 days). At bivariate analysis, prompt ART initiation was less likely among women who reported sex work as their main job (OR sex work_vs_other job or no job: = 0.48, 95% CI 0.30–0.79), and young women (OR < 25_vs_ ≥ 35: = 0.39, 95% CI 0.20–0.77) and (OR 25–29_vs_ ≥ 35: = 0.44, 95% CI 0.23–0.83). Prompt ART initiation was more likely among those who became eligible after 12 months of implementing the intervention (OR 1.79, 95% CI 1.05–3.06) compared to those who became eligible during the first 12 months.

At adjusted analysis, when compared with women aged ≥ 35 years, prompt ART initiation was less likely among young women aged < 25 years; (AOR0.28, 95% CI 0.13–0.61) and those aged 25–29 years (AOR 0.40, 95% CI 0.20–0.79). Prompt ART was also less likely among women who reported sex work as their main job (AOR 0.44; 95% CI 0.25–0.78) compared to those reporting other job(s) or no job. Regarding marital status widowed/separated women were less likely to initiate prompt ART (AOR 0.45; 95% CI 0.23–0.86) compared to never married women. Those who became eligible for the ‘test and treat’ intervention after 12 months of its implementation were more likely to initiate prompt ART (AOR 2.58; 95% CI 1.41–4.71) compared to those who became eligible during the first 12 months of the intervention as shown in Table 2.

Table 2.

Multivariable model for factors associated with prompt ART initiation

Characteristic N (col %) Prompt ART N (row %) Unadjusted OR (95% CI) LRT P value Adjusted OR (95% CI) P value
343 96(28)
Age 0.03
 ≥ 35 71(21.0) 30(42.3) 1 1
 < 25 90(26.0) 20(22.2) 0.39(0.20–0.77) 0.28(0.13–0.61) 0.001
 25–29 111(32.0) 27(24.3) 0.44(0.23–0.83) 0.40(0.20–0.79) 0.009
 30–34 71(21.0) 19(26.8) 0.50(0.25–1.01) 0.54(0.26–1.16) 0.116
Current marital status 0.106
 Never married 67(19.5) 23(34.3) 1 1
 Married 24(7.0) 10(41.7) 1.37(0.53–3.55) 0.80(0.28–2.34) 0.69
 Widowed/separated 252(73.5) 63(25.0) 0.64(0.36–1.14) 0.45(0.23–0.86) 0.016
Religion 0.441
 Muslim and other 118(34.4) 30(25.4) 1
 Christian 225(65.6) 66(29.3) 1.22(0.74–2.02)
Education level 0.935
 No education 31(9.0) 9(29) 1
 Primary 207(60.4) 59(28.5) 0.97(0.42–2.24)
 Secondary or higher 105(30.6) 28(26.7) 0.89(0.37–2.16)
Main job 0.004
 No job/other jobs 119(34.7) 45(37.8) 1 1
 Sex work 224(65.3) 51(22.8) 0.48(0.30–0.79) 0.44(0.25–0.78) 0.005
Paid sex in past 3 months 0.174
 No 19(5.5) 8(42.1) 1 1
 Yes 324(94.5) 88(27.2) 0.51(0.20–1.32) 0.89(0.30–2.69) 0.838
Drinking pattern (AUDIT score) 0.083
 Low risk drinkers 132(38.5) 44(33.3) 1 1
 High risk drinkers 211(61.5) 52(24.6) 0.65(0.41–1.06) 0.61(0.35–1.04) 0.072
Drug use in past 3 months 0.722
 Yes 120(35.0) 61(27.3) 1 1
 No 223(65.0) 35(29.2) 1.09(0.67–1.79) 1.50(0.85–2.66) 0.161
Sexual partner violence in past 3 months 0.167
 No 176(51.3) 55(31.2) 1 1
 Yes 167(48.7) 41(24.6) 0.72(0.45–1.15) 0.67(0.39–1.14) 0.137
HIV sero-conversion 0.775
 No 312(91.0) 88(28.2) 1
 Yes 31(9.0) 8(25.8) 0.89(0.38–2.05)
Ever tested for HIV 0.235
 No 45(13.1) 16(35.6) 1
 Yes 298(86.9) 80(26.9) 0.67(0.34–1.29)
Time since T&T implementation 0.029
 ≤ 12 months 112(32.7) 23(20.5) 1 1
 > 12 months 231(67.3) 73(31.6) 1.79(1.05–3.06) 2.58(1.41–4.71) 0.002

Discussion

We found that a low proportion of women initiated prompt ART compared to other studies that have examined the delivery of the test and treat intervention [1921]. Iwuji and colleagues, for example, report high ART uptake, however this was only observed in those who linked to care [35]; overall, ART uptake in that trial was still low considering that almost half of HIV-positive individuals did not link to care within 6 months. We report prompt ART as initiating within 1 month while others [20, 21, 35] have reported initiation between 3 and 6 months. The shorter duration may further explain lower uptake in our study.

Women who reported sex work as their main job were less likely to initiate prompt ART compared to those who reported other jobs or no job. Structural and social barriers may hinder prompt ART initiation among FSWs in our setting where sex work is still criminalized. Communities worldwide still exhibit varied levels of stigma and discrimination against FSWs [36, 37]. To avoid these negative consequences, many FSWs do not reveal their HIV-positive status to community members. Many do not want to be seen with pills because taking ART is one way of exposing their HIV-positive status making them lose clients and money [38]. The lifestyle of FSWs also poses barriers to prompt ART initiation because of working hours which do not allow time to make initial clinic visits to start and stabilize on treatment, and fear of being isolated from the FSW support structures if found taking ART [38, 39]. Increased efforts are needed to create a sex worker-supportive environment and partnerships using community mobilization among FSWs in order to facilitate universal access to HIV prevention services and identify acceptable ART delivery strategies [40].

In our study women aged less than 30 years had a lower likelihood of prompt ART initiation; the odds were however lower among young women (< 25 years) compared to those aged 25–29 years. Studies done among key populations elsewhere [24, 4143], and the general population have also found prompt ART initiation less likely among young people. Initiation of prompt ART at a young age means, potentially, many years on ART; this requires a lifelong commitment which may not be a priority for young HIV-positive people who are not sick. In addition, young people are not fully economically independent and may not have resources to support clinic visits for ART initiation and early follow required before they are stable on treatment. In sex work settings, younger HIV-positive women experience more unequal power relations, gender inequities, limited social support and intimate partner violence when compared to older women [44], which affects their ability to engage with community social services including initiating prompt ART [45].

We observed that ART initiation was less likely among widowed and separated women compared to those who were never married. Similar findings have been reported from the general population in sub-Saharan Africa [46, 47] and elsewhere [48]. Widowhood and divorce/separation are still associated with stigma and shame in many developing communities [49, 50]. Widows and separated/divorced women may experience rejection and violence from in-laws and former spouses [4952]. This social marginalization coupled with engagement in sex work may further reduce their opportunities for a social support system that facilitates disclosure of HIV status and the subsequent decision to initiate ART.

We found that women who were more recently enrolled in the cohort (after 12 months of implementing ‘test and treat’), were more likely to initiate prompt ART. This finding is consistent with other studies [22, 53, 54]. We attribute the higher likelihood of prompt ART initiation in later months to increased staff confidence and experience with the new ART initiation guidelines. It is also likely that the intervention was more popular among the women after 1 year of implementation increasing the likelihood of prompt ART initiation. We however note, that even though prompt ART initiation was more likely among the recently enrolled women, the proportion who initiated was still very low suggesting that staff experience alone does not lead to improved ART uptake.

Study Limitations

One of our main limitations was missing data on one or more variables for 55 women that were excluded from the final analysis. This could have reduced our power of predicting prompt ART initiation. We did not assess for health facility factors, the study staff received training before and during implementation of test and treat, drugs, clinic and laboratory supplies and registers for documentation were always available. Women received comprehensive health care in addition to HIV care and treatment; the role of the health facility could have been limited. Furthermore, we did not collect data on the reasons for non-uptake of prompt ART for those that did not initiate. Such data could inform future strategies aimed at improving prompt ART among key populations.

Conclusion

We found a low uptake of prompt ART among FSWs. Our findings provide information that highlights the need to target young women, those whose main job is sex work, and the widowed/separated for prompt ART initiation. FSWs should be involved in the design and implementation of tailored interventions that provide an enabling environment to support them. This approach together with community engagement activities through peer educators and health workers enables close follow up of all HIV positive FSWs for purposes of continued education about prompt ART and could play an important role in prompt ART initiation and increased ART coverage in this population. In addition, regular supervision and mentoring activities for clinical care need more support during the first year; they include but are not limited to: staff training, ART knowledge and skills assessment, document review to ensure accurate and consistent data capture and participant satisfaction surveys.

Acknowledgements

The work was jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and is also part of the EDCTP2 program supported by the European Union. The clinic receives support from PEPFAR through the Centers for Disease Control and Prevention for the provision of clinical services.

Compliance with Ethical Standards

Conflicts of interest

The authors have no conflicts of interest to declare.

Ethical Approval

The Uganda National Council for Science and Technology (HS 364) and Uganda Virus Research Institute-Research Ethics Committee (GC/127/14/10/30) approved the study. Written informed consent was obtained from all participants. We kept confidentiality by use of numerical identifiers during data collection. All data were de-identified prior to analysis.

Footnotes

The original version of this article was revised: The incorrect range (10–51%) has been corrected in the second sentence of the Introduction section.

A correction to this article is available online at https://doi.org/10.1007/s10461-017-1998-9.

References

  • 1.Baral S, Beyrer C, Muessig K, et al. Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(7):538–549. doi: 10.1016/S1473-3099(12)70066-X. [DOI] [PubMed] [Google Scholar]
  • 2.Beyrer C, Baral SD, van Griensven F, et al. Global epidemiology of HIV infection in men who have sex with men. Lancet. 2012;380(9839):367–377. doi: 10.1016/S0140-6736(12)60821-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kiwanuka N, Ssetaala A, Mpendo J, et al. High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda. J Int AIDS Soc. 2013;16(1):18621. doi: 10.7448/IAS.16.1.18621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Poteat T, Scheim A, Xavier J, Reisner S, Baral S. Global epidemiology of HIV infection and related syndemics affecting transgender people. J Acquir Immune Defic Syndr. 2016;72(Suppl 3):S210–S219. doi: 10.1097/QAI.0000000000001087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Strathdee SA, Stockman JK. Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions. Curr HIV/AIDS Rep. 2010;7:99–106. doi: 10.1007/s11904-010-0043-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Gelmon L. HIV prevention response and modes of transmission analysis. Nairobi: Kenya National AIDS Control Council; 2009. [Google Scholar]
  • 7.Joint United Nations Programme on HIV/AIDS . New HIV infections by mode of transmission in West Africa: a multicountry analysis. Geneva: Joint United Nations Programme on HIV/AIDS; 2010. [Google Scholar]
  • 8.Wabwire-Mangen F, Odiit M, Kirungi W, Kaweesa Kisitu D, Wanyama JO. Uganda HIV prevention response and modes of transmission analysis. Kampala: Uganda AIDS Commission; 2009. [Google Scholar]
  • 9.Uganda AIDS Commission . HIV and AIDS Uganda Country progress report; 2013. Kampala: Uganda AIDS Commission; 2014. [Google Scholar]
  • 10.Vandepitte J, Bukenya J, Weiss HA, et al. HIV and other sexually transmitted infections in a cohort of women involved in high-risk sexual behavior in Kampala, Uganda. Sex Transm Dis. 2011;38(4):316–323. [PMC free article] [PubMed] [Google Scholar]
  • 11.Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. New Engl J Med. 2011;365(6):493–505. doi: 10.1056/NEJMoa1105243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sigaloff KC, Lange JM, Montaner J. Global response to HIV: treatment as prevention, or treatment for treatment? Clin Infect Dis. 2014;59(Suppl 1):S7–S11. doi: 10.1093/cid/ciu267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.The Lancet HIV. The end of AIDS? Lancet HIV. 2015;2(3):e71. doi: 10.1016/S2352-3018(15)00029-6. [DOI] [PubMed] [Google Scholar]
  • 14.Uganda Ministry of Health. Addendum to the National Antiretroviral Treatment Guidelines. Kampala: Ministry of Health, Government of the Republic of Uganda; 2013.
  • 15.Lundgren JD, Babiker AG, Gordin F, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807. doi: 10.1056/NEJMoa1506816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.World Health Organisation . Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV Guidelines. Geneva: World Health Organisation; 2015. [PubMed] [Google Scholar]
  • 17.Lancet The. HIV: the question is not when to treat, but how to treat. Lancet. 2015;386:1420. doi: 10.1016/S0140-6736(15)00454-7. [DOI] [PubMed] [Google Scholar]
  • 18.World Health Organization . Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: WHO; 2016. [PubMed] [Google Scholar]
  • 19.Boyer S, Iwuji C, Gosset A, et al. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa. AIDS Care. 2016;28(Suppl 3):39. doi: 10.1080/09540121.2016.1164808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Charurat ME, Emmanuel B, Akolo C, et al. Uptake of treatment as prevention for HIV and continuum of care among HIV-positive men who have sex with men in Nigeria. J Acquir Immune Defic Syndr. 2015;68(Suppl 2):S114–S123. doi: 10.1097/QAI.0000000000000439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Hayes R, Floyd S, Schaap A, et al. A universal testing and treatment intervention to improve HIV control: one-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial. PLoS Med. 2017;14(5):e1002292. doi: 10.1371/journal.pmed.1002292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hsu LC. Truong H-HM, Vittinghoff E, Zhi Q, Scheer S, Schwarcz S. Trends in early initiation of antiretroviral therapy and characteristics of persons with HIV initiating therapy in San Francisco, 2007–2011. J Infect Dis. 2013;209(9):1310–1314. doi: 10.1093/infdis/jit599. [DOI] [PubMed] [Google Scholar]
  • 23.Katz IT, Essien T, Marinda ET, et al. Antiretroviral therapy refusal among newly diagnosed HIV-infected adults. AIDS. 2011;25(17):2177–2181. doi: 10.1097/QAD.0b013e32834b6464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Liu Y, Ruan Y, Vermund SH, et al. Predictors of antiretroviral therapy initiation: a cross-sectional study among Chinese HIV-infected men who have sex with men. BMC Infect Dis. 2015;15(1):570. doi: 10.1186/s12879-015-1309-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Mbonye M, Seeley J, Nalugya R, et al. Test and treat: the early experiences in a clinic serving women at high risk of HIV infection in Kampala. AIDS Care. 2016;28(Suppl 3):33–38. doi: 10.1080/09540121.2016.1164804. [DOI] [PubMed] [Google Scholar]
  • 26.Knight R, Small W, Thomson K, Gilbert M, Shoveller J. Implementation challenges and opportunities for HIV treatment as prevention (TasP) among young men in Vancouver, Canada: a qualitative study. BMC Public Health. 2016;16:262. doi: 10.1186/s12889-016-2943-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.De Cock KM. Plus ca change antiretroviral therapy, HIV prevention, and the HIV treatment cascade. Clin Infect Dis. 2014;58(7):1012–1014. doi: 10.1093/cid/ciu026. [DOI] [PubMed] [Google Scholar]
  • 28.Evans C, Bennett J, Croston M, Brito-Ault N, Bruton J. “In reality, it is complex and difficult”: UK nurses’ perspectives on “treatment as prevention” within HIV care. AIDS Care. 2015;27(6):753–757. doi: 10.1080/09540121.2014.1002826. [DOI] [PubMed] [Google Scholar]
  • 29.Karim QA, Dellar RC, Bearnot B, et al. HIV-positive status disclosure in patients in care in Rural South Africa: implications for scaling up treatment and prevention interventions. AIDS Behav. 2015;19(2):322–329. doi: 10.1007/s10461-014-0951-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Sugarman J. Bioethical challenges with HIV Treatment as prevention. Clin Infect Dis. 2014;59(suppl 1):S32–S34. doi: 10.1093/cid/ciu246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Wilson D, Fraser N. Who pays and why? Costs, effectiveness, and feasibility of HIV treatment as prevention. Clin Infect Dis. 2014;59(suppl 1):S28–S31. doi: 10.1093/cid/ciu300. [DOI] [PubMed] [Google Scholar]
  • 32.Kamali A, Nsubuga R, Ruzagira E, et al. Heterogeneity of HIV incidence: a comparative analysis between fishing communities and in a neighbouring rural general population, Uganda, and implications for HIV control. Sex Transm Infect. 2016;92(6):447. doi: 10.1136/sextrans-2015-052179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Gregson J, Kaleebu P, Marconi VC, et al. Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study. Lancet Infect Dis. 2017;17(3):296–304. doi: 10.1016/S1473-3099(16)30469-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Uganda Ministry of Health . Addendum to the National Antiretorviral Treatment Guidelines. Kampala: Ministry of Health, Government of the Republic of Uganda; 2013. [Google Scholar]
  • 35.Iwuji CC, Orne-Gliemann J, Larmarange J, et al. Uptake of home-based HIV testing, linkage to care, and community attitudes about ART in Rural KwaZulu-Natal, South Africa: descriptive results from the first phase of the ANRS 12249 TasP cluster-randomised trial. PLoS Med. 2016;13(8):e1002107. doi: 10.1371/journal.pmed.1002107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Decker MR, Crago A-L, Chu SK, et al. Human rights violations against sex workers: burden and effect on HIV. Lancet. 2015;385(9963):186–199. doi: 10.1016/S0140-6736(14)60800-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.King EJ, Maman S, Bowling JM, Moracco KE, Dudina V. The influence of stigma and discrimination on female sex workers’ access to HIV services in St. Petersburg, Russia. AIDS Behav. 2013;17(8):2597–2603. doi: 10.1007/s10461-013-0447-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Chakrapani V, Newman PA, Shunmugam M, Kurian AK, Dubrow R. Barriers to free antiretroviral treatment access for female sex workers in Chennai, India. AIDS Patient Care STDs. 2009;23(11):973–980. doi: 10.1089/apc.2009.0035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Mbonye M, Rutakumwa R, Weiss H, Seeley J. Alcohol consumption and high risk sexual behaviour among female sex workers in Uganda. Afr J AIDS Res. 2014;13(2):145–151. doi: 10.2989/16085906.2014.927779. [DOI] [PubMed] [Google Scholar]
  • 40.Joint United Nations Programme on HIV/AIDS . UNAIDS guidance note on HIV and sex work. Geneva: Joint United Nations Programme on HIV/AIDS; 2012. [PubMed] [Google Scholar]
  • 41.Cooke GS, Tanser FC, Bärnighausen TW, Newell M-L. Population uptake of antiretroviral treatment through primary care in rural South Africa. BMC Public Health. 2010;10(1):585. doi: 10.1186/1471-2458-10-585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Goldenberg SM, Montaner J, Duff P, et al. Structural barriers to antiretroviral therapy among sex workers living with HIV: findings of a longitudinal study in Vancouver, Canada. AIDS Behav. 2016;20(5):977. doi: 10.1007/s10461-015-1102-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Mao L, Wit J, Kippax S, Prestage G, Holt M. Younger age, recent HIV diagnosis, no welfare support and no annual sexually transmissible infection screening are associated with nonuse of antiretroviral therapy among HIV-positive gay men in Australia. HIV Med. 2015;16(1):32–37. doi: 10.1111/hiv.12169. [DOI] [PubMed] [Google Scholar]
  • 44.Mbonye M, Nalukenge W, Nakamanya S, et al. Gender inequity in the lives of women involved in sex work in Kampala. Uganda. J Int AIDS Soc. 2012;15(Suppl 1):1–9. doi: 10.7448/IAS.15.3.17365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Moon T, Burlison J, Blevins M, et al. Enrolment and programmatic trends and predictors of antiretroviral therapy initiation from president’s emergency plan for AIDS Relief (PEPFAR)-supported public HIV care and treatment sites in rural Mozambique. Int J STD AIDS. 2011;22(11):621–627. doi: 10.1258/ijsa.2011.010442. [DOI] [PubMed] [Google Scholar]
  • 46.Katz IT, Essien T, Marinda ET, et al. Antiretroviral refusal among newly diagnosed HIV-infected adults in Soweto, South Africa. AIDS. 2011;25(17):2177. doi: 10.1097/QAD.0b013e32834b6464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Lahuerta M, Lima J, Nuwagaba-Biribonwoha H, et al. Factors associated with late antiretroviral therapy initiation among adults in Mozambique. PLoS ONE. 2012;7(5):e37125. doi: 10.1371/journal.pone.0037125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Alvarez-Uria G, Pakam R, Midde M, Naik PK. Predictors of delayed antiretroviral therapy initiation, mortality, and loss to followup in HIV infected patients eligible for HIV treatment: data from an HIV cohort study in India. Biomed Res Int. 2013;2013:849042. doi: 10.1155/2013/849042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Sahoo DM. An analysis of widowhood in India: A global perspective. International Journal of Multidisciplinary and Current Research. 2014;2.
  • 50.Widows for peace through democracy. Dossier on widowhood: issues of discrmination for the attention of CEDAW. 2016.
  • 51.Brownridge DA, Hiebert-Murphy D, Ristock J, et al. Violence against separated, divorced, and married women in Canada, 2004. J Divorce Remarriage. 2008;49(3–4):308–329. doi: 10.1080/10502550802222121. [DOI] [Google Scholar]
  • 52.Fleury RE, Sullivan CM, Bybee DI. When ending the relationship does not end the violence women’s experiences of violence by former partners. Violence Against Women. 2000;6(12):1363–1383. doi: 10.1177/10778010022183695. [DOI] [Google Scholar]
  • 53.Teasdale CA, Wang C, Francois U, et al. Time to initiation of antiretroviral therapy among patients who are ART eligible in Rwanda: improvement over time. J Acquir Immune Defic Syndr. 2015;68(3):314. doi: 10.1097/QAI.0000000000000432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Wright ST, Law MG, Cooper DA, et al. Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia. J Int AIDS Soc. 2015;18(1):19463. doi: 10.7448/IAS.18.1.19463. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from AIDS and Behavior are provided here courtesy of Springer

RESOURCES